We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleSorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis.AuthorsEisen T; Ahmad T; Flaherty KT; Gore M; Kaye S; Marais R; Gibbens I; Hackett S; James M; Schuchter LM; Nathanson KL; Xia C; Simantov R; Schwartz B; Poulin-Costello M; O'Dwyer PJ; Ratain MJPublicationBritish journal of cancer, 2006, Vol 95, Issue 5, p581ISSN0007-0920Publication typearticleDOI10.1038/sj.bjc.6603291